Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mantle Cell Lymphoma; Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02669017
What this trial is testing

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Who this might be right for
Non-Hodgkin LymphomaBurkitt's LymphomaChronic Lymphocytic Leukemia+6 more
ADC Therapeutics S.A. 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802590
What this trial is testing

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
The Lymphoma Academic Research Organisation 210
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT02952508
What this trial is testing

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

Who this might be right for
Waldenstrom MacroglobulinemiaMultiple MyelomaChronic Lymphocytic Leukemia+6 more
Cellectar Biosciences, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT06561425
What this trial is testing

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Lakefront Biotherapeutics NV 130
Testing effectiveness (Phase 2)Study completedNCT01261247
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more
Mayo Clinic 41
Testing effectiveness (Phase 2)UnknownNCT01322776
What this trial is testing

Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma Recurrent
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT00918333
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more
Mayo Clinic 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT05471843
What this trial is testing

Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell LymphomaRefractory Mantle Cell Lymphoma (MCL)Relapsed Mantle Cell Lymphoma
BeOne Medicines 125
Early research (Phase 1)Ended earlyNCT02931110
What this trial is testing

Study of IV CBL0137 in Previously Treated Hematological Subjects

Who this might be right for
Hematological Malignancies
Incuron 5
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06029309
What this trial is testing

Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Alvaro Alencar, MD 27
Early research (Phase 1)Ended earlyNCT00003567
What this trial is testing

Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00962507
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
City of Hope Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06341556
What this trial is testing

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell LymphomaMaintenance Therapy
Fudan University 52
Testing effectiveness (Phase 2)Study completedNCT00004105
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaSarcoma+1 more
NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT03037645
What this trial is testing

Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoplasmacytoid Lymphoma+5 more
Sunesis Pharmaceuticals 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684950
What this trial is testing

Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy

Who this might be right for
Mantle Cell Lymphoma (MCL)
Henan Cancer Hospital 45
Testing effectiveness (Phase 2)UnknownNCT02652910
What this trial is testing

Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell Lymphoma+6 more
Xinqiao Hospital of Chongqing 20
Testing effectiveness (Phase 2)Ended earlyNCT02455297
What this trial is testing

Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Who this might be right for
Lymphoma, Mantle-Cell
Bayer 4
Next Page